PUBLIC COMPANY
save$KZRKezar Life Sciences, Inc.
$KZRSouth San Francisco, CA, USupdated 21d ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)
- phase1KZR-261 in Subjects With Advanced Solid Malignancies
- phase2A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)
- phase2A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis
- phase2Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM.
- phase2A Study of KZR-616 in Patients With SLE With and Without Lupus Nephritis
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 16m ago
Found something off?
comments(0)
5-min edit window · permanent after that